Congress funds menopause research and training for millions of women
H.R. 9090 — Advancing Menopause Care and Mid-Life Women’s Health Act · Filed by Yvette Clarke (D-NY) · 13 cosponsors · Introduced Jun 2, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Department of Health and Human Services to expand research, training, public awareness, and clinical care programs focused on menopause and mid-life women's health. It authorizes $25 million annually for research and data collection, $10 million for public health promotion and grants to improve early detection and care coordination, $10 million for a national awareness and education program, and $10 million for training programs at medical schools and hospitals—totaling $55 million per year through 2031. The bill also establishes Centers of Excellence to improve provider training and requires annual reporting on progress and health disparities.
Why we flagged it
The bill is a straightforward federal investment in menopause research, provider education, and public health infrastructure. It does not create new regulatory authority, tax incentives, or private-sector carve-outs; it funds HHS to conduct and coordinate existing public-health functions.
What the text implies
- Establishes a federal data dashboard on menopausal symptoms and health outcomes, creating a new longitudinal dataset that may inform future policy on women's health, aging, and workplace accommodations.
- Occupational health research component may generate evidence supporting workplace accommodations or disability protections for women experiencing severe menopausal symptoms, with potential downstream regulatory or litigation implications.
- Centers of Excellence designation and geographic distribution requirements may shift research and training resources toward rural and underserved areas, potentially reducing concentration of menopause expertise in academic medical centers.
- Emphasis on 'integrated, collaborative approaches to care' and mental health/substance use prevention may expand scope of menopause treatment beyond traditional hormone replacement therapy to include behavioral health integration.
Who it affects
Ordinary women gain access to better-researched, better-trained care for a common health transition affecting millions. The bill funds research into a historically under-studied condition, trains providers, removes barriers to diagnosis and treatment, and prioritizes rural and underserved populations. No direct costs to citizens; benefits are broadly distributed across the female population.
Who stands to gain
- accredited medical schools and nursing schools
- teaching hospitals and residency programs
- community health centers
- state and local public health departments
- research institutions
Named in the bill
Department of Health and Human Services (HHS), Public Health Service Act, House Committee on Energy and Commerce, Committee on Appropriations, Committee on Health, Education, Labor, and Pensions, Committee on Finance, Special Committee on Aging, Committee on Ways and Means, Department of Veterans Affairs, Department of Defense, accredited schools of medicine, accredited schools of nursing — and 5 more
Where it stands
13 cosponsors: 12 Democrats, 1 Republicans.
- Jun 2, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jun 2, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $96,000 in lobbying spend. A filing names 31 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Yvette Clarke, the sponsor, reported $626,107 in PAC receipts in the 2026 cycle.
- American College of Obstetricians and Gynecologists — $96,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the full bill text on Jul 5, 2026; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress funds menopause research and training for millions of women” QuorumCivic. https://share.quorumcivic.app/bill/119/hr9090 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.